Considerations for Potential Future Therapeutic Use of Psychedelic Drugs Public Hearing

Considerations for Potential Future Therapeutic Use of Psychedelic Drugs Public Hearing is organized by U.S. Food and Drug Administration (FDA) and will be held on Sep 14, 2026 at U.S. Food and Drug Administration, Silver Spring, Maryland, United States of America.

Description:
The U.S. Food and Drug Administration (FDA) is announcing a public hearing, held in collaboration with federal partners, to obtain feedback and perspectives on issues associated with the potential future therapeutic use of drug products containing a psychedelic drug substance in supervised and supportive settings.